L’Oréal and Geno create bio-based alternatives to key ingredients in beauty products

wp-image-799665490jpg.jpg
Christophe Schilling, CEO of Genomatica during his speech at the Grand Opening of Mater Biotech’s plant in Bottrighe di Adria, Italy

L’Oréal invested in a venture led by Geno, the California-headquartered biotechnology company, to create sustainable alternatives to key ingredients in beauty products. The French multinational company will be a founding member of the venture alongside Unilever and Kao.

Continue reading